Medscape Podcasts
Keeping Current
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
No dejes de visitar la web del podcast y apoyar a su creador: keepingcurrent.webmd.libsynpro.com
Autor
Medscape Podcasts
Categoría
Web del podcast
Último episodio
20 de oct. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Instálala gratis
Android casi 10 M de descargas · valoración de 4,8
iOS muy pronto
Episodios
COPD: Patient Selection Based on GOLD Guidance and Response to Therapy 31.03.2020 20:44
In this against-the-clock activity, a pulmonologist and primary care physician answer key questions on dual bronchodilator therapy for COPD. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/926217?src=mkm_podcast_addon_926217
CAR T-Cell Therapy in Non-Hodgkin Lymphoma and Multiple Myeloma: A Clinical Update 21.03.2020 36:37
Listen to the experts discuss the current and emerging role of CAR T-cell therapy in NHL and MM. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/924229?src=mkm_podcast_addon_924229
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice 26.12.2019 40:01
Experts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/923019?src=mkm_podcast_addon_923019
Idiopathic Pulmonary Fibrosis: The Right Treatments at the Right Time 14.12.2019 20:05
Drs Vancheri and Wijsenbeek discuss the need for early treatment of IPF and the pharmacologic/non-pharmacologic options currently available. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/921539?src=mkm_podcast_addon_921539
Approaching a New Era in the Management of Progressive Fibrosing ILDs 15.11.2019 45:12
Join Dr Flaherty and colleagues as they present the emerging data and clinical implications related to the use of antifibrotics in PF-ILDs. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/920726?src=mkm_podcast_addon_920726
How Can We Meet the Treatment Needs of Patients With Systemic Sclerosis-Interstitial Lung Disease? 19.09.2019 33:23
Join Drs Distler and Hoffmann-Vold as they discuss current and emerging treatments for SSc-ILD and their clinical impact Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/917034?src=mkm_podcast_addon_917034
Working Together to Diagnose Idiopathic Pulmonary Fibrosis 20.08.2019 33:40
Join Dr Cottin and colleagues as they discuss the importance of recognizing IPF and the latest guidelines for the diagnosis. Earn Credit / Learning Objectives & Disclosures --- Full URLs: Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/916396?src=mkm_podcast_addon_916396
The Progressive Phenotype of Non-IPF ILD: Clinical Relevance and Identification 28.06.2019 43:54
Join Dr. Kolb and colleagues covering the etiology, pathophysiology, monitoring, and emerging treatments for non-IPF progressive fibrosing ILDs Learning Objectives & Disclosures --- Full URLs: Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/914675?src=mkm_podcast_addon_914675
Podcasts similares
Escucha el podcast Keeping Current en Replaio
Radio y podcasts en una sola app - gratis y sin registro. Instálala hoy y no te pierdas el estreno
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos
